Jared Kelly

Chief Executive Officer at ONCOLYTICS BIOTECH INC.

Net worth: 118 612 $ as of 31/05/2026

40 year

23 connections

Health Technology

Commercial Services

Consumer Services

Profile

Jared Kelly is currently Chief Executive Officer & Director at Oncolytics Biotech, Inc. since 2025.
Mr. Kelly is also Secretary, Senior Vice President & General Counsel at Ambrx Biopharma Cayman, Inc. since 2023.
Formerly, Mr. Kelly was a Partner at Lowenstein Sandler LLP.
Mr. Kelly completed graduate studies at Georgetown University Law Center.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ONCOLYTICS BIOTECH INC. 0.1%	01/06/2026	114,050 ( 0.1% )	118 612 $	31/05/2026

Jared Kelly active positions

Companies	Position	Start
ONCOLYTICS BIOTECH INC.	Chief Executive Officer	11/06/2025
Ambrx Biopharma, Inc. Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company	General Counsel	13/09/2023

All active positions of Jared Kelly

Former positions of Jared Kelly

Companies	Position	End
Lowenstein Sandler LLP Lowenstein Sandler LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services	Corporate Officer/Principal	-

See the detail of Jared Kelly's experience

Training of Jared Kelly

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jared Kelly's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Oncolytics Biotech, Inc. Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers	Health Technology
Lowenstein Sandler LLP Lowenstein Sandler LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services	Commercial Services
Georgetown University Law Center Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ambrx Biopharma, Inc. Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company	Health Technology